Knowledge (XXG)

Pracinostat

Source 📝

227: 24: 399:
Pracinostat selectively inhibits HDAC class I, II, IV without class III and HDAC6 in class IIb, but has no effect on other Zn-binding enzymes, receptors, and ion channels. It accumulates in tumor cells and exerts a continuous inhibition to histone deacetylase, resulting in acetylated histones
574: 416:
Clinical studies suggests that pracinostat has potential best pharmacokinetic properties when compared to other oral HDAC inhibitors. In March 2014, pracinostat has granted
108: 567: 276: 465:"The oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AML" 834: 560: 514:"SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer" 250:
InChI=1S/C20H30N4O2/c1-4-7-8-19-21-17-15-16(10-12-20(25)22-26)9-11-18(17)24(19)14-13-23(5-2)6-3/h9-12,15,26H,4-8,13-14H2,1-3H3,(H,22,25)/b12-10+
463:
Novotny-Diermayr, V.; Hart, S.; Goh, K. C.; Cheong, A.; Ong, L-C; Hentze, H.; Pasha, M. K.; Jayaraman, R.; Ethirajulu, K.; Wood, J. M. (2012).
260:
InChI=1/C20H30N4O2/c1-4-7-8-19-21-17-15-16(10-12-20(25)22-26)9-11-18(17)24(19)14-13-23(5-2)6-3/h9-12,15,26H,4-8,13-14H2,1-3H3,(H,22,25)/b12-10+
241: 849: 391:
with potential anti-tumor activity characterized by favorable physicochemical, pharmaceutical, and pharmacokinetic properties.
583: 364: 814: 429: 184: 205: 844: 421: 599: 401: 594: 839: 744: 789: 36: 222: 74: 659: 639: 759: 784: 674: 669: 649: 535: 494: 148: 749: 609: 525: 484: 476: 299: 84: 193: 734: 614: 425: 388: 226: 128: 764: 739: 704: 489: 464: 384: 358: 828: 173: 774: 769: 754: 699: 694: 684: 629: 513: 530: 552: 449: 719: 714: 689: 679: 604: 417: 799: 794: 724: 664: 654: 624: 333: 139: 779: 729: 634: 405: 539: 498: 644: 619: 480: 23: 346: 160: 357:
Except where otherwise noted, data are given for materials in their
119: 107: 97: 556: 210: 512:
Veronica Novotny-Diermayr; et al. (March 9, 2010).
400:
accumulation, chromatin remodeling, tumor suppressor
172: 83: 284:CCCCC1=NC2=C(N1CCN(CC)CC)C=CC(=C2)/C=C/C(=O)NO 568: 8: 450:"In vitro enzyme activity of SB939 and SAHA" 383:) is an orally bioavailable, small-molecule 575: 561: 553: 225: 147: 15: 600:β-Hydroxybutyric acid (β-hydroxybutyrate) 529: 488: 192: 441: 281: 246: 221: 253:Key: JHDKZFFAIZKUCU-ZRDIBKRKSA-N 127: 7: 385:histone deacetylase (HDAC) inhibitor 263:Key: JHDKZFFAIZKUCU-ZRDIBKRKBK 163: 14: 317: 311: 22: 610:Acetoacetic acid (acetoacetate) 424:(AML) and for the treatment of 361:(at 25 °C , 100 kPa). 835:Histone deacetylase inhibitors 584:Histone deacetylase inhibitors 323: 305: 1: 815:Receptor/signaling modulators 531:10.1158/1535-7163.MCT-09-0689 430:Food and Drug Administration 740:Sodium oxybate (GHB sodium) 866: 808: 780:Valproic acid (valproate) 590: 422:acute myelocytic leukemia 355: 292: 272: 237: 67: 59: 35: 30: 21: 49:-1,3-benzimidazol-5-yl}- 630:Butyric acid (butyrate) 850:Diethylamino compounds 53:-hydroxyprop-2-enamide 745:Sodium phenylbutyrate 595:3,3'-Diindolylmethane 790:Valproate semisodium 469:Blood Cancer Journal 37:Preferred IUPAC name 481:10.1038/bcj.2012.14 412:Clinical medication 402:genes transcription 341: g·mol 18: 404:, and ultimately, 365:Infobox references 16: 822: 821: 800:Vorinostat (SAHA) 785:Valproate pivoxil 670:Indole-3-carbinol 650:Diallyl disulfide 373:Chemical compound 371: 370: 206:CompTox Dashboard 109:Interactive image 45:)-3-{2-Butyl-1--1 857: 845:Hydroxamic acids 750:Sodium valproate 577: 570: 563: 554: 544: 543: 533: 509: 503: 502: 492: 460: 454: 453: 446: 408:of tumor cells. 340: 325: 319: 313: 307: 300:Chemical formula 230: 229: 214: 212: 196: 176: 165: 151: 131: 111: 87: 26: 19: 865: 864: 860: 859: 858: 856: 855: 854: 825: 824: 823: 818: 804: 735:Sodium butyrate 615:Allyl mercaptan 586: 581: 550: 548: 547: 518:Mol Cancer Ther 511: 510: 506: 462: 461: 457: 448: 447: 443: 438: 426:T-cell lymphoma 414: 397: 389:hydroxamic acid 374: 367: 362: 338: 328: 322: 316: 310: 302: 288: 285: 280: 279: 268: 265: 264: 261: 255: 254: 251: 245: 244: 233: 215: 208: 199: 179: 166: 154: 134: 114: 101: 90: 77: 63: 55: 54: 12: 11: 5: 863: 861: 853: 852: 847: 842: 840:Benzimidazoles 837: 827: 826: 820: 819: 809: 806: 805: 803: 802: 797: 792: 787: 782: 777: 772: 767: 765:Trichostatin A 762: 757: 752: 747: 742: 737: 732: 727: 722: 717: 712: 707: 705:Phenylbutyrate 702: 697: 692: 687: 682: 677: 672: 667: 662: 657: 652: 647: 642: 637: 632: 627: 622: 617: 612: 607: 602: 597: 591: 588: 587: 582: 580: 579: 572: 565: 557: 546: 545: 524:(3): 642–652. 504: 455: 452:. 22 Aug 2014. 440: 439: 437: 434: 413: 410: 396: 393: 372: 369: 368: 363: 359:standard state 356: 353: 352: 349: 343: 342: 336: 330: 329: 326: 320: 314: 308: 303: 298: 295: 294: 290: 289: 287: 286: 283: 275: 274: 273: 270: 269: 267: 266: 262: 259: 258: 256: 252: 249: 248: 240: 239: 238: 235: 234: 232: 231: 223:DTXSID00239196 218: 216: 204: 201: 200: 198: 197: 189: 187: 181: 180: 178: 177: 169: 167: 159: 156: 155: 153: 152: 144: 142: 136: 135: 133: 132: 124: 122: 116: 115: 113: 112: 104: 102: 95: 92: 91: 89: 88: 80: 78: 73: 70: 69: 65: 64: 61: 57: 56: 40: 39: 33: 32: 28: 27: 13: 10: 9: 6: 4: 3: 2: 862: 851: 848: 846: 843: 841: 838: 836: 833: 832: 830: 817: 816: 813: 807: 801: 798: 796: 793: 791: 788: 786: 783: 781: 778: 776: 773: 771: 768: 766: 763: 761: 758: 756: 753: 751: 748: 746: 743: 741: 738: 736: 733: 731: 728: 726: 723: 721: 718: 716: 713: 711: 708: 706: 703: 701: 698: 696: 693: 691: 688: 686: 683: 681: 678: 676: 673: 671: 668: 666: 663: 661: 658: 656: 653: 651: 648: 646: 643: 641: 638: 636: 633: 631: 628: 626: 623: 621: 618: 616: 613: 611: 608: 606: 603: 601: 598: 596: 593: 592: 589: 585: 578: 573: 571: 566: 564: 559: 558: 555: 551: 541: 537: 532: 527: 523: 519: 515: 508: 505: 500: 496: 491: 486: 482: 478: 474: 470: 466: 459: 456: 451: 445: 442: 435: 433: 431: 427: 423: 419: 411: 409: 407: 403: 394: 392: 390: 386: 382: 378: 366: 360: 354: 351:1.1±0.1 g/cm 350: 348: 345: 344: 337: 335: 332: 331: 304: 301: 297: 296: 291: 282: 278: 271: 257: 247: 243: 236: 228: 224: 220: 219: 217: 207: 203: 202: 195: 191: 190: 188: 186: 183: 182: 175: 171: 170: 168: 162: 158: 157: 150: 146: 145: 143: 141: 138: 137: 130: 126: 125: 123: 121: 118: 117: 110: 106: 105: 103: 99: 94: 93: 86: 82: 81: 79: 76: 72: 71: 66: 58: 52: 48: 44: 38: 34: 29: 25: 20: 811: 810: 775:Valnoctamide 770:Tucidinostat 755:Sulforaphane 709: 700:Parthenolide 695:Panobinostat 685:Mocetinostat 660:Fimepinostat 640:Citarinostat 549: 521: 517: 507: 472: 468: 458: 444: 415: 398: 380: 376: 375: 68:Identifiers 60:Other names 50: 46: 42: 17:Pracinostat 720:Resminostat 715:Quisinostat 710:Pracinostat 690:Niacinamide 680:Martinostat 605:Abexinostat 475:(5): e69–. 418:Orphan Drug 377:Pracinostat 293:Properties 129:CHEBI:95071 85:929016-96-6 62:Pracinostat 829:Categories 795:Valpromide 760:Trapoxin B 725:Romidepsin 665:Givinostat 655:Entinostat 625:Belinostat 436:References 334:Molar mass 194:GPO2JN4UON 140:ChemSpider 96:3D model ( 75:CAS Number 812:See also: 730:Scriptaid 635:Capsaicin 406:apoptosis 387:based on 675:Kevetrin 645:Curcumin 620:Apicidin 540:20197387 499:22829971 395:Activity 174:49855250 149:25027185 490:3366067 428:by the 347:Density 339:358.486 161:PubChem 538:  497:  487:  277:SMILES 31:Names 381:SB939 242:InChI 120:ChEBI 98:JSmol 536:PMID 495:PMID 420:for 185:UNII 526:doi 485:PMC 477:doi 211:EPA 164:CID 831:: 534:. 520:. 516:. 493:. 483:. 471:. 467:. 432:. 315:30 309:20 41:(2 576:e 569:t 562:v 542:. 528:: 522:9 501:. 479:: 473:2 379:( 327:2 324:O 321:4 318:N 312:H 306:C 213:) 209:( 100:) 51:N 47:H 43:E

Index


Preferred IUPAC name
CAS Number
929016-96-6
JSmol
Interactive image
ChEBI
CHEBI:95071
ChemSpider
25027185
PubChem
49855250
UNII
GPO2JN4UON
CompTox Dashboard
DTXSID00239196
Edit this at Wikidata
InChI
SMILES
Chemical formula
Molar mass
Density
standard state
Infobox references
histone deacetylase (HDAC) inhibitor
hydroxamic acid
genes transcription
apoptosis
Orphan Drug
acute myelocytic leukemia

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.